Vilin Bio Med Limited (NSE:VILINBIO)
India
· Delayed Price · Currency is INR 38.10
+0.70 (1.87%)
Apr 29, 2026, 1:14 PM IST
Vilin Bio Med Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Operating Revenue | 199.81 | 148.1 | 158.05 | 123.13 | 112.15 | 117.15 | Upgrade
|
| Other Revenue | - | - | - | 0.24 | 0.04 | 0.04 | Upgrade
|
| Revenue | 199.81 | 148.1 | 158.05 | 123.37 | 112.19 | 117.19 | Upgrade
|
| Revenue Growth (YoY) | 52.70% | -6.30% | 28.11% | 9.97% | -4.26% | -30.34% | Upgrade
|
| Cost of Revenue | 186.79 | 134.9 | 130.31 | 72.64 | 89.77 | 90.39 | Upgrade
|
| Gross Profit | 13.02 | 13.2 | 27.74 | 50.74 | 22.42 | 26.8 | Upgrade
|
| Selling, General & Admin | 3.48 | 2.95 | 8.07 | 7.77 | 8.57 | 10.67 | Upgrade
|
| Other Operating Expenses | 2.53 | 2.38 | 11.51 | 16.99 | 6.15 | 7.53 | Upgrade
|
| Operating Expenses | 7.05 | 6.38 | 20.88 | 26.44 | 16.92 | 20.77 | Upgrade
|
| Operating Income | 5.97 | 6.83 | 6.87 | 24.3 | 5.51 | 6.03 | Upgrade
|
| Interest Expense | -5.04 | -8.45 | -7.8 | -6.49 | -4.95 | -4.15 | Upgrade
|
| Interest & Investment Income | 4.69 | 4.69 | 3.24 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -2.16 | -0 | -0.05 | 0 | -0.11 | -0.27 | Upgrade
|
| Pretax Income | 3.46 | 3.06 | 2.25 | 17.82 | 0.45 | 1.61 | Upgrade
|
| Income Tax Expense | 0.95 | 0.82 | 0.63 | 5.37 | 0.11 | 0.4 | Upgrade
|
| Net Income | 2.51 | 2.24 | 1.62 | 12.45 | 0.34 | 1.21 | Upgrade
|
| Net Income to Common | 2.51 | 2.24 | 1.62 | 12.45 | 0.34 | 1.21 | Upgrade
|
| Net Income Growth | - | 37.62% | -86.96% | 3605.36% | -72.30% | -25.22% | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 14 | 10 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 14 | 10 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | 0.47% | - | 40.20% | 20.61% | - | - | Upgrade
|
| EPS (Basic) | 0.18 | 0.16 | 0.12 | 1.25 | 0.04 | 0.15 | Upgrade
|
| EPS (Diluted) | 0.18 | 0.16 | 0.12 | 1.25 | 0.04 | 0.15 | Upgrade
|
| EPS Growth | - | 37.44% | -90.69% | 3025.00% | -72.80% | -25.22% | Upgrade
|
| Free Cash Flow | -17.55 | -13.57 | -74.22 | -16.88 | 2.09 | -10.02 | Upgrade
|
| Free Cash Flow Per Share | -1.26 | -0.97 | -5.32 | -1.70 | 0.25 | -1.21 | Upgrade
|
| Gross Margin | 6.51% | 8.91% | 17.55% | 41.13% | 19.98% | 22.87% | Upgrade
|
| Operating Margin | 2.99% | 4.61% | 4.34% | 19.70% | 4.91% | 5.15% | Upgrade
|
| Profit Margin | 1.26% | 1.51% | 1.03% | 10.09% | 0.30% | 1.03% | Upgrade
|
| Free Cash Flow Margin | -8.78% | -9.16% | -46.96% | -13.68% | 1.86% | -8.55% | Upgrade
|
| EBITDA | 7.02 | 7.87 | 8.17 | 25.98 | 7.7 | 8.6 | Upgrade
|
| EBITDA Margin | 3.51% | 5.31% | 5.17% | 21.05% | 6.86% | 7.34% | Upgrade
|
| D&A For EBITDA | 1.05 | 1.04 | 1.3 | 1.68 | 2.19 | 2.57 | Upgrade
|
| EBIT | 5.97 | 6.83 | 6.87 | 24.3 | 5.51 | 6.03 | Upgrade
|
| EBIT Margin | 2.99% | 4.61% | 4.34% | 19.70% | 4.91% | 5.15% | Upgrade
|
| Effective Tax Rate | 27.47% | 26.91% | 27.85% | 30.12% | 24.83% | 24.75% | Upgrade
|
| Revenue as Reported | 202.33 | 152.78 | 161.29 | 123.37 | 112.19 | 117.19 | Upgrade
|
| Advertising Expenses | - | - | 0.03 | - | 0.08 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.